Two Sigma Investments’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-330,902
| Closed | -$1.93M | – | 3674 |
|
|
2025
Q1 | $1.93M | Buy |
330,902
+111,583
| +51% | +$588K | ﹤0.01% | 1759 |
|
|
2024
Q4 | $816K | Buy |
219,319
+62,568
| +40% | +$289K | ﹤0.01% | 2302 |
|
|
2024
Q3 | $876K | Sell |
156,751
-164,374
| -51% | -$1.15M | ﹤0.01% | 2204 |
|
|
2024
Q2 | $2.7M | Sell |
321,125
-159,134
| -33% | -$1.7M | 0.01% | 1356 |
|
|
2024
Q1 | $6.93M | Sell |
480,259
-33,892
| -7% | -$560K | 0.02% | 802 |
|
|
2023
Q4 | $11.1M | Buy |
514,151
+7,401
| +1% | +$132K | 0.03% | 634 |
|
|
2023
Q3 | $9.74M | Sell |
506,750
-44,615
| -8% | -$952K | 0.03% | 615 |
|
|
2023
Q2 | $14M | Buy |
551,365
+64,748
| +13% | +$1.87M | 0.04% | 507 |
|
|
2023
Q1 | $17.6M | Buy |
486,617
+80,133
| +20% | +$2.81M | 0.05% | 409 |
|
|
2022
Q4 | $16.1M | Buy |
406,484
+61,907
| +18% | +$2.57M | 0.05% | 408 |
|
|
2022
Q3 | $16.1M | Buy |
344,577
+105
| +0% | +$4.87K | 0.05% | 366 |
|
|
2022
Q2 | $15.1M | Sell |
344,472
-50,805
| -13% | -$2.79M | 0.05% | 391 |
|
|
2022
Q1 | $28.6M | Sell |
395,277
-18,491
| -4% | -$1.33M | 0.08% | 299 |
|
|
2021
Q4 | $33.5M | Buy |
+413,768
| New | +$41.5M | 0.07% | 319 |
|
|
2021
Q2 | – | Sell |
-34,480
| Closed | -$5.38M | – | 4668 |
|
|
2021
Q1 | $4.81M | Buy |
34,480
+23,283
| +208% | +$3.8M | 0.01% | 1070 |
|
|
2020
Q4 | $1.94M | Sell |
11,197
-25,576
| -70% | -$4.14M | 0.01% | 1512 |
|
|
2020
Q3 | $5.12M | Sell |
36,773
-40,473
| -52% | -$5.41M | 0.02% | 788 |
|
|
2020
Q2 | $9.23M | Sell |
77,246
-39,561
| -34% | -$4.69M | 0.05% | 413 |
|
|
2020
Q1 | $11.7M | Sell |
116,807
-156,321
| -57% | -$18.8M | 0.1% | 221 |
|
|
2019
Q4 | $32.1M | Buy |
273,128
+189,979
| +228% | +$18.8M | 0.1% | 250 |
|
|
2019
Q3 | $7.15M | Buy |
83,149
+72,112
| +653% | +$5.46M | 0.02% | 692 |
|
|
2019
Q2 | $716K | Sell |
11,037
-76,754
| -87% | -$4.78M | ﹤0.01% | 2219 |
|
|
2019
Q1 | $5.49M | Buy |
87,791
+80,317
| +1,075% | +$3.78M | 0.02% | 914 |
|
|
2018
Q4 | $291K | Buy |
+7,474
| New | +$332K | ﹤0.01% | 2473 |
|
|
2016
Q1 | – | Sell |
-6,526
| Closed | -$441K | – | 3187 |
|
|
2015
Q4 | $441K | Buy |
+6,526
| New | +$349K | ﹤0.01% | 2040 |
|
|
2015
Q3 | – | Sell |
-41,420
| Closed | -$2.23M | – | 2831 |
|
|
2015
Q2 | $2.23M | Buy |
+41,420
| New | +$2.11M | 0.01% | 1136 |
|
Other funds holding NVRO
Two Sigma Investments's NVRO Position: Q2 2025 in Review
Two Sigma Investments sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 330,902 shares — an estimated $1.93M sold.
Two Sigma Investments first reported a position in NVRO in Q2 2015 and held it in 26 quarters. The position peaked at $33.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Two Sigma Investments reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Two Sigma Investments sold 330,902 NEVRO CORP. shares in Q2 2025, an estimated $1.93M.
- Two Sigma Investments first reported a position in NEVRO CORP. in Q2 2015 and held it in 26 quarters.
- Two Sigma Investments's NEVRO CORP. position peaked at $33.5M in Q4 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.